[¹⁸F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer

Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3950-3951. doi: 10.1007/s00259-022-05828-3. Epub 2022 May 4.

Authors

A-L Deleu¹, N Ahmadi Bidakhvidi^{1

2}, L Van Wynsberge³, K Van Laere^{1

2}, G De Meerleer⁴, K Goffin^{1

2}

Affiliations

¹ Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
² Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
³ Department of Urology, Tienen Regional Hospital, Tienen, Belgium.
⁴ Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.

PMID: 35507060
DOI: 10.1007/s00259-022-05828-3

No abstract available

MeSH terms

Gallium Radioisotopes
Humans
Male
Niacinamide / analogs & derivatives
Oligopeptides
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms* / diagnostic imaging

Substances

Gallium Radioisotopes
Oligopeptides
PSMA-1007
Niacinamide